论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Liu Y, Lyu S, Wang X, Wang Y
Received 7 February 2018
Accepted for publication 9 August 2018
Published 4 December 2018 Volume 2018:11 Pages 8685—8693
DOI https://doi.org/10.2147/OTT.S164880
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Cristina Weinberg
Peer reviewer comments 2
Editor who approved publication: Dr Jianmin Xu
Objective: This
study aimed to investigate the application of preoperative three-dimensional
model design in radioactive particle implantation for advanced pancreatic
cancer, and accordingly analyze the effect of particle implantation in the
treatment of advanced pancreatic cancer.
Methods: The
clinical data of 63 patients with advanced pancreatic cancer treated with
particle implantation from January 2009 to June 2015 in the General Hospital of
Chinese PLA were retrospectively analyzed. The implantation design was
conducted using the FitMe three-dimensional model reconstruction software for
all patients before the operation to explore the significance of preoperative
three-dimensional model design in guiding operation. These data were compared
with the general data, postoperative recovery, and follow-ups of patients with
advanced pancreatic cancer, who underwent conservative treatment at the same
time period, in order to explore the effect of particle implantation in the
treatment of advanced pancreatic cancer.
Results: In the 63
patients with advanced pancreatic cancer who underwent particle implantation,
the average number of implanted particles was 53.4±18.7. Gastroparesis occurred
in 17 patients and pancreatic fistula occurred in 13 patients after the
operation, and no perioperative death occurred.
Follow-up results: In the
particle group, the relief rate of abdominal pain was 90.9%, the 1-month,
6-month, 1-year, and 2-year survival rates were 100%, 58.7%, 22.4%, and 9%,
respectively, and median survival time was 10.4±0.7 months, which were
significantly higher than patients in the control group (P <0.05),
especially in patients with stage III pancreatic cancer.
Conclusion: For
patients with advanced pancreatic cancer who could not undergo radical
resection, radioactive particle implantation is an effective treatment, while
the use of a preoperative three-dimensional model design for operation planning
can maximize the effect of radioactive particles.
Keywords: pancreatic
cancer, radiotherapy, 125I particle, 3D
model, survival analysis
